ATE486540T1 - Verwendung von alginat-matrizen zur kontrolle des zellwachstums - Google Patents

Verwendung von alginat-matrizen zur kontrolle des zellwachstums

Info

Publication number
ATE486540T1
ATE486540T1 AT04815696T AT04815696T ATE486540T1 AT E486540 T1 ATE486540 T1 AT E486540T1 AT 04815696 T AT04815696 T AT 04815696T AT 04815696 T AT04815696 T AT 04815696T AT E486540 T1 ATE486540 T1 AT E486540T1
Authority
AT
Austria
Prior art keywords
disclosed
alginate
methods
cell growth
devices
Prior art date
Application number
AT04815696T
Other languages
English (en)
Inventor
Jan Melvik
Michael Dornish
Original Assignee
Fmc Biopolymer As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Biopolymer As filed Critical Fmc Biopolymer As
Application granted granted Critical
Publication of ATE486540T1 publication Critical patent/ATE486540T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT04815696T 2003-12-23 2004-12-23 Verwendung von alginat-matrizen zur kontrolle des zellwachstums ATE486540T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53191703P 2003-12-23 2003-12-23
PCT/US2004/043681 WO2005063147A1 (en) 2003-12-23 2004-12-23 Use of alginate matrices to control cell growth

Publications (1)

Publication Number Publication Date
ATE486540T1 true ATE486540T1 (de) 2010-11-15

Family

ID=34738717

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04815696T ATE486540T1 (de) 2003-12-23 2004-12-23 Verwendung von alginat-matrizen zur kontrolle des zellwachstums

Country Status (13)

Country Link
US (2) US7790193B2 (de)
EP (2) EP1696825B1 (de)
JP (2) JP4869945B2 (de)
CN (1) CN1897890B (de)
AT (1) ATE486540T1 (de)
AU (1) AU2004308511B2 (de)
BR (1) BRPI0417776A (de)
CA (1) CA2548305C (de)
DE (1) DE602004029928D1 (de)
IL (2) IL176268A0 (de)
MX (1) MXPA06006930A (de)
NZ (1) NZ547829A (de)
WO (1) WO2005063147A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2564044T3 (es) * 2003-06-27 2016-03-17 DePuy Synthes Products, Inc. Células posparto derivadas de tejido del cordón umbilical y métodos de preparación y uso de las mismas
MXPA06006930A (es) 2003-12-23 2007-01-26 Fmc Biopolymer As Uso de matrices de alginato para controlar la proliferacion celular.
AU2005295927B2 (en) * 2004-10-12 2012-02-02 Fmc Biopolymer As Self-gelling alginate systems and uses thereof
US9028872B2 (en) * 2006-03-01 2015-05-12 Fmc Corporation Gelled composite
WO2007147014A2 (en) * 2006-06-13 2007-12-21 Fmc Biopolymer As Method and systems for using biopolymer-based beads and hydrogels
US8168215B2 (en) * 2006-06-16 2012-05-01 Fmc Biopolymer As Alginate coated, collagen matrix cellular device, preparative methods, and uses thereof
US20090209019A1 (en) * 2006-10-17 2009-08-20 Tokai University Educational System Bioartificial Renal Tubule
DE102006054789B4 (de) * 2006-11-21 2008-09-25 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren und Vorrichtung zur Behandlung biologischer Zellen auf einem Substrat
WO2008157324A2 (en) * 2007-06-13 2008-12-24 Fmc Corporation Peptide linked cell matrix materials for stem cells and methods of using the same
US8809521B2 (en) * 2007-08-28 2014-08-19 Fmc Biopolymer As Delayed self-gelling alginate systems and uses thereof
US9056150B2 (en) * 2007-12-04 2015-06-16 Warsaw Orthopedic, Inc. Compositions for treating bone defects
US8734527B2 (en) * 2007-12-20 2014-05-27 Advanced Technologies And Regenerative Medicine, Llc Encapsulated kidney tissue
WO2010032242A1 (en) 2008-09-17 2010-03-25 Beta O2 Technologies Ltd. Optimization of alginate encapsulation of islets for transplantation
US9446168B2 (en) 2010-06-07 2016-09-20 Beta-O2 Technologies Ltd. Multiple-layer immune barrier for donor cells
WO2012127224A1 (en) * 2011-03-21 2012-09-27 University Of Reading Transport of cells in hydrogels
EP4083074A1 (de) 2011-06-02 2022-11-02 Massachusetts Institute Of Technology Modifizierte alginate für zellverkapselung und zelltherapie
CN104922682A (zh) * 2014-03-20 2015-09-23 中国科学院大连化学物理研究所 一种胰蛋白酶抑制剂及其应用
CA2956075C (en) * 2014-08-01 2020-03-10 Massachusetts Institute Of Technology Modified alginates for anti-fibrotic materials and applications
WO2017075630A1 (en) 2015-11-01 2017-05-04 Massachusetts Institute Of Technology Materials with improved properties
ES2978718T3 (es) 2015-11-01 2024-09-18 Massachusetts Inst Technology Alginatos modificados para materiales antifibróticos y aplicaciones
US20180327703A1 (en) * 2015-11-25 2018-11-15 Nutech Ventures Large scale cell manufacture system
JP2019501808A (ja) * 2016-04-04 2019-01-24 ベータ−オーツー・テクノロジーズ・リミテッドＢｅｔａ−Ｏ２ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｌｔｄ． 抗炎症能および血管新生能を有する細胞の移植のための移植可能デバイスならびにそれを製造する方法
CA3027200A1 (en) 2016-06-13 2017-12-21 Massachusetts Institute Of Technology Biocompatible zwitterionic polymer coatings and hydrogels for reducing foreign body response and fibrosis
WO2019090309A1 (en) 2017-11-06 2019-05-09 Massachusetts Institute Of Technology Anti-inflammatory coatings to improve biocompatibility of neurological implants
GB201801014D0 (en) * 2018-01-22 2018-03-07 Univ Newcastle Storage and/or transport for multicellular aggregates
CN113573746A (zh) * 2019-03-20 2021-10-29 公立大学法人横滨市立大学 包覆固定剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459054A (en) * 1989-12-05 1995-10-17 Neocrin Company Cells encapsulated in alginate containing a high content of a- l- guluronic acid
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5643594A (en) * 1992-05-29 1997-07-01 The Regents Of The University Of California Spin encapsulation apparatus and method of use
US5531716A (en) * 1993-09-29 1996-07-02 Hercules Incorporated Medical devices subject to triggered disintegration
US5876742A (en) * 1994-01-24 1999-03-02 The Regents Of The University Of California Biological tissue transplant coated with stabilized multilayer alginate coating suitable for transplantation and method of preparation thereof
US5900238A (en) * 1995-07-27 1999-05-04 Immunex Corporation Vaccine delivery system
EP1015042A1 (de) 1997-09-19 2000-07-05 Reprogenesis, Inc Verbessertes hydrogel für die gewebetechnologie
JP3261456B2 (ja) * 1999-10-29 2002-03-04 独立行政法人産業技術総合研究所 細胞培養担体及び該担体を用いた細胞の培養方法
US6638917B1 (en) * 2000-02-25 2003-10-28 Scimed Life Systems, Inc. Reducing adhesion
AU9118201A (en) * 2000-09-20 2002-04-02 Islet Sheet Medical Llc Improved methods for fabrication of thin sheet bio-artificial organs
JP2003259862A (ja) * 2002-03-12 2003-09-16 Fuji Photo Film Co Ltd 細胞培養担体
MXPA06006930A (es) 2003-12-23 2007-01-26 Fmc Biopolymer As Uso de matrices de alginato para controlar la proliferacion celular.

Also Published As

Publication number Publication date
US20050169895A1 (en) 2005-08-04
EP2228035A1 (de) 2010-09-15
AU2004308511B2 (en) 2010-09-16
JP5410401B2 (ja) 2014-02-05
IL176268A0 (en) 2006-10-05
US20100304484A1 (en) 2010-12-02
JP2011032290A (ja) 2011-02-17
CA2548305A1 (en) 2005-07-14
AU2004308511A1 (en) 2005-07-14
CN1897890B (zh) 2012-01-25
WO2005063147A1 (en) 2005-07-14
BRPI0417776A (pt) 2007-03-20
US7790193B2 (en) 2010-09-07
MXPA06006930A (es) 2007-01-26
EP1696825A1 (de) 2006-09-06
JP2007517051A (ja) 2007-06-28
CA2548305C (en) 2014-07-15
IL205151A (en) 2012-02-29
NZ547829A (en) 2009-04-30
US8541017B2 (en) 2013-09-24
EP1696825B1 (de) 2010-11-03
EP1696825A4 (de) 2008-05-14
CN1897890A (zh) 2007-01-17
DE602004029928D1 (de) 2010-12-16
JP4869945B2 (ja) 2012-02-08

Similar Documents

Publication Publication Date Title
DE602004029928D1 (de) Verwendung von alginat-matrizen zur kontrolle des zellwachstums
Barois et al. Ecology of earthworm species with large environmental tolerance and/or extended distributions
DE69630891T2 (de) Unterstützungsvorrichtung für pflanzenkultur und anwendungsmethode zum pflanzenwuchs
PT794790E (pt) Libertacao localizada de factores que aumentam a sobrevivencia de celulas transplantadas
DE59710789D1 (de) Verfahren zur herstellung von knorpelgewebe und von implantaten
ATE356838T1 (de) Biosynthetische matrix und deren verwendung
DE60135019D1 (de) Elektroverarbeitetes kollagen
WO2000017322A3 (en) Electroactive materials for stimulation of biological activity of cells
US20040005297A1 (en) Biological scaffold
ATE142511T1 (de) In vivo-neomorphogenese von knorpel aus zellkulturen
GB1455360A (en) Porous synthetic materials
WO2002059277A3 (en) Electroactive materials for stimulation of biological activity of stem cells
WO2004113513A3 (en) Methods and compositions for modulating stem cell growth and differentiation
DE69634828D1 (de) Auffindbare künstliche bioimplantate
Hevly Adaptations of cheilanthoid ferns to desert environments
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
DE3751843D1 (de) Herstellung von körperorganen durch kontroliertes zellwachstum auf künstlicher matrix
DK0549774T3 (da) Anvendelse af porøst calciumcarbonat som bærermateriale for in vitro cellekulturer
WO2002076285A3 (en) Composition and methods fro the production of biological tissues and tissue constructs
WO2002018441A3 (en) Electroprocessed fibrin-based matrices and tissues
WO2003099230A3 (en) Electroprocessed collagen and tissue engineering
JPH06503735A (ja) 創傷用包帯剤およびその製造法
WO2007005828A3 (en) Cell growth and cell transplant devices for gene therapy
ATE197961T1 (de) Stromale zellinien aus menschlichem knochenmark und ihre verwendung
CN208151069U (zh) 一种净化水质的复合景观生态浮床

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties